A study led by researchers from RISE-Health was covered by several national media organisations.
The scientific paper “Bitter Taste Signalling via TAS2R43 Enhances Temozolomide Efficacy in Glioblastoma Cells”, led by researchers Cecília Santos and Ana Raquel Costa, was featured today by Agência Lusa to mark International Brain Tumour Day, and was picked up by several national media outlets.
The study identified bitter taste receptors as a potential new therapeutic target in the fight against glioblastoma, one of the most aggressive and difficult-to-treat malignant brain tumours.
The report by Agência Lusa led to the story being published in various national media outlets, including Notícias ao Minuto, SIC Notícias, CNN Portugal, SAPO, Jornal da Madeira, DNotícias, Notícias de Coimbra, Saúde+TV and Health News.
The research explores the unexpected role of receptors associated with bitter taste in the behaviour of tumour cells, opening up new avenues for the development of more effective therapeutic strategies against this type of brain cancer.
The extensive media coverage has helped to bring scientific research closer to the public, reinforcing the importance of science communication and the dissemination of scientific advances with potential clinical impact.
Media outlets that highlighted the study:
The study’s coverage in various national media outlets reflects society’s growing interest in innovative biomedical research and the development of new therapeutic approaches for aggressive brain tumours.